Fractalkine Modulates Microglia Metabolism in Brain Ischemia.

CX3CL1 ischemia microglia neuroinflammation neuroprotection

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2019
Historique:
received: 31 01 2019
accepted: 27 08 2019
entrez: 15 10 2019
pubmed: 15 10 2019
medline: 15 10 2019
Statut: epublish

Résumé

In the CNS, the chemokine CX3CL1 (fractalkine) is expressed on neurons while its specific receptor CX3CR1 is expressed on microglia and macrophages. Microglia play an important role in health and disease through CX3CL1/CX3CR1 signaling, and in many neurodegenerative disorders, microglia dysregulation has been associated with neuro-inflammation. We have previously shown that CX3CL1 has neuroprotective effects against cerebral ischemia injury. Here, we investigated the involvement of CX3CL1 in the modulation of microglia phenotype and the underlying neuroprotective effect on ischemia injury. The expression profiles of anti- and pro-inflammatory genes showed that CX3CL1 markedly inhibited microglial activation both

Identifiants

pubmed: 31607865
doi: 10.3389/fncel.2019.00414
pmc: PMC6755341
doi:

Types de publication

Journal Article

Langues

eng

Pagination

414

Informations de copyright

Copyright © 2019 Lauro, Chece, Monaco, Antonangeli, Peruzzi, Rinaldo, Paone, Cutruzzolà and Limatola.

Références

Br J Pharmacol. 2016 Feb;173(4):649-65
pubmed: 25800044
PLoS One. 2011;6(8):e23902
pubmed: 21901144
FASEB J. 2006 Apr;20(6):714-6
pubmed: 16473887
Blood. 2010 Jun 10;115(23):4742-9
pubmed: 20351312
Crit Rev Neurobiol. 2006;18(1-2):145-57
pubmed: 17725517
Mol Biol Rep. 2011 Jan;38(1):481-8
pubmed: 20364328
Curr Opin Pharmacol. 2006 Aug;6(4):379-86
pubmed: 16713356
Nat Rev Immunol. 2011 Oct 10;11(11):762-74
pubmed: 21984070
Front Integr Neurosci. 2013 Aug 13;7:59
pubmed: 23964211
J Neuroinflammation. 2013 Sep 18;10:115
pubmed: 24047275
Acta Pharmacol Sin. 2011 Feb;32(2):188-93
pubmed: 21293471
Ann N Y Acad Sci. 2015 Sep;1351:141-8
pubmed: 26084002
J Pharmacol Exp Ther. 2006 Aug;318(2):849-54
pubmed: 16705080
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Clin Biochem. 2013 Oct;46(15):1339-52
pubmed: 23680095
J Cereb Blood Flow Metab. 2008 Oct;28(10):1707-21
pubmed: 18575457
Nat Immunol. 2016 Jul;17(7):797-805
pubmed: 27135602
Cell Physiol Biochem. 2015;35(4):1571-81
pubmed: 25790769
J Neuroimmunol. 2009 May 29;210(1-2):3-12
pubmed: 19269040
Glia. 2014 Dec;62(12):1932-42
pubmed: 24995657
Curr Drug Targets Cardiovasc Haematol Disord. 2004 Mar;4(1):65-84
pubmed: 15032653
Nat Med. 2011 Jul 07;17(7):796-808
pubmed: 21738161
J Neuroinflammation. 2013 Jan 11;10:4
pubmed: 23311642
Stroke. 1997 Feb;28(2):382-6
pubmed: 9040694
J Neurosci Res. 2014 Jun;92(6):723-31
pubmed: 24510633
J Neurosci. 2011 Nov 9;31(45):16327-35
pubmed: 22072684
Acta Neuropathol. 2014 Sep;128(3):363-80
pubmed: 25107477
Stroke. 2012 Nov;43(11):3063-70
pubmed: 22933588
Front Cell Neurosci. 2014 Jul 10;8:193
pubmed: 25071451
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10896-901
pubmed: 9724801
PLoS One. 2010 Jul 23;5(7):e11746
pubmed: 20668522
Neuropsychopharmacology. 2010 Jun;35(7):1550-9
pubmed: 20200508
Cell. 2017 Aug 10;170(4):649-663.e13
pubmed: 28802038
Neurol Res Int. 2017;2017:1524548
pubmed: 28713592
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Glia. 2013 Jun;61(6):827-42
pubmed: 23440897
Prog Neurobiol. 2017 Oct;157:247-272
pubmed: 26851161
Nat Rev Neurosci. 2007 Jan;8(1):57-69
pubmed: 17180163
Cell Death Dis. 2016 Apr 07;7:e2174
pubmed: 27054329
FEBS Lett. 2013 Mar 18;587(6):756-62
pubmed: 23395614
Brain Res. 2003 Jul 25;979(1-2):65-70
pubmed: 12850572
Nat Neurosci. 2006 Jul;9(7):917-24
pubmed: 16732273
J Immunol. 2010 Jul 1;185(1):605-14
pubmed: 20498354
Physiol Rev. 2011 Apr;91(2):461-553
pubmed: 21527731
Neurosci Lett. 2001 May 4;303(2):132-6
pubmed: 11311510
Mol Neurobiol. 2014 Jun;49(3):1422-34
pubmed: 24395130
J Neurosci. 2000 Aug 1;20(15):RC87
pubmed: 10899174
Nat Rev Cancer. 2004 Jul;4(7):551-61
pubmed: 15229480
J Biol Chem. 2011 Sep 16;286(37):32713-22
pubmed: 21771791
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
Trends Neurosci. 2007 Nov;30(11):596-602
pubmed: 17950926
J Neuroinflammation. 2011 Jan 25;8:9
pubmed: 21266082
Annu Rev Pathol. 2011;6:275-97
pubmed: 21034223
Cell Res. 2015 Jul;25(7):771-84
pubmed: 26045163
BMC Neurosci. 2010 Feb 02;11:12
pubmed: 20122276
J Neuroinflammation. 2011 Dec 10;8:174
pubmed: 22152337
Nature. 2007 Apr 26;446(7139):1091-5
pubmed: 17410128
Glia. 2001 Mar 1;33(3):256-66
pubmed: 11241743
CNS Neurol Disord Drug Targets. 2016;15(3):329-36
pubmed: 26831258
Neurobiol Aging. 2011 Mar;32(3):443-58
pubmed: 19368990
J Immunol. 2000 Jun 15;164(12):6166-73
pubmed: 10843666
Clin Dev Immunol. 2013;2013:746068
pubmed: 24223607
Front Mol Neurosci. 2017 Aug 14;10:261
pubmed: 28855861
Front Neurol. 2015 Apr 08;6:81
pubmed: 25904895
Open Biol. 2013 Dec 18;3(12):130181
pubmed: 24352739
Nat Neurosci. 2005 Jun;8(6):752-8
pubmed: 15895084
Cell Metab. 2012 Apr 4;15(4):432-7
pubmed: 22482726
J Cereb Blood Flow Metab. 2007 Mar;27(3):488-500
pubmed: 16820801
Glia. 2008 Feb;56(3):259-70
pubmed: 18069670
Nature. 2013 Jan 17;493(7432):346-55
pubmed: 23325217
J Biol Chem. 2011 Jan 21;286(3):2308-19
pubmed: 21071446
Curr Opin Neurol. 2001 Feb;14(1):89-94
pubmed: 11176223
Stroke. 2001 May;32(5):1208-15
pubmed: 11340235
Science. 1956 Aug 10;124(3215):269-70
pubmed: 13351639
J Neuroimmunol. 2005 Sep;166(1-2):19-28
pubmed: 16019082
J Neuroinflammation. 2010 Nov 01;7:74
pubmed: 21040547
Nat Neurosci. 2013 Nov;16(11):1618-26
pubmed: 24077561
Eur J Neurosci. 2002 May;15(10):1663-8
pubmed: 12059974
Mol Cell Biol. 2000 Jun;20(11):4106-14
pubmed: 10805752
Glia. 2003 Mar;41(4):371-81
pubmed: 12555204
Glia. 2000 Feb 15;29(4):305-15
pubmed: 10652441
J Neurosci. 2007 Mar 7;27(10):2596-605
pubmed: 17344397
Bull World Health Organ. 2016 Sep 1;94(9):634-634A
pubmed: 27708464
Science. 2005 May 27;308(5726):1314-8
pubmed: 15831717
Nat Neurosci. 2011 Sep 27;14(10):1227-35
pubmed: 21952260
Science. 2007 Mar 23;315(5819):1671-2
pubmed: 17379794
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):E4098-107
pubmed: 24101459

Auteurs

Clotilde Lauro (C)

Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.

Giuseppina Chece (G)

Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.

Lucia Monaco (L)

Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.

Fabrizio Antonangeli (F)

Department of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.

Giovanna Peruzzi (G)

Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy.

Serena Rinaldo (S)

Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy.

Alessio Paone (A)

Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy.

Francesca Cutruzzolà (F)

Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy.

Cristina Limatola (C)

Department of Physiology and Pharmacology, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
IRCCS NeuroMed, Pozzilli, Italy.

Classifications MeSH